Quốc gia: Israel
Ngôn ngữ: Tiếng Do Thái
Nguồn: Ministry of Health
ODEVIXIBAT AS SESQUIHYDRATE
MEDISON PHARMA LTD
A05AX05
קפסולה קשיחה
ODEVIXIBAT AS SESQUIHYDRATE 400 MCG
פומי
מרשם נדרש
ALBIREO AB, SWEDEN
ODEVIXIBAT
2023-01-05
1 ) ( " - 1986 200 400 600 1,200 : 200 " : 200 " ( - ,) 200 mcg odevixibat (as sesquihydrate) 400 " : 400 " ( - ,) 400 mcg odevixibat (as sesquihydrate) 600 " : 600 " ( - ,) 600 mcg odevixibat (as sesquihydrate) 1,200 " : 1,200 " ( - ,) 1,200 mcg odevixibat (as sesquihydrate) - 6 ." " . . , . . . . 1 . ? : • )" "( - ( PFIC – progressive familial intrahepatic cholestasis ) 6 . PFIC ) ( . • 12 ( ' Alagille Syndrome – ALGS .) . , . , , . . : . 2 . X : • ( ) ( 6 " .)" 2 : , • . • . • , , , , PFIC , . . . - PFIC 6 6 . - ALGS 12 12 . . . . A , D - E INR . / , , , . A , D - E , . , , . . . , . . 3 . ? . . . . . . - PFIC 6 • 40 . • 3 , - 120 ( 7,200 .) 3 - ALGS 12 • 120 . . . . . 200 - 600 . 400 - 1,200 , . : • ( 2 / 30 , , " , , .) . • . • . • . • . • . • . . • . • . 4 6 . , . , . , . . . . . , . ! . . , . 4 . . , . . : ( - 1 10 ) • , , . • • • • , , . " " ) www.health.gov.il ( , " : https://sideeffects.health.gov.il 5 . ? • ! / . . • ( (exp. date . . • : - 25°C . . 5 • . . . 6 . : : Microcrystalline cellulose (MCC) spheres 700 Hypromellose 3mPa.s : _ _ _יוו_ _י_ 200 _ _ _מ_ _ _ _ק_ " _ _ _ _ _ יוו_ _י_ _ו_ 600 _קמ_ " _ _ _ _ _ _ _ו_ _ק _ _וסומ_ _ _ Hypromellose Titanium dioxide Yellow iron oxide (E172) _ יוו_ _י_ 400 _ _ _קמ_ " _ו _ - 1,200 _ _ _מ_ _ _ _ק_ " _ וק _ _וסומ _ _ _ Hypromellose Titanium dioxide Yellow iron oxide (E172) Red iron oxide (E172) Shellac glaze in ethanol Black iron oxide N-butyl alcohol Isopropyl alcohol Propylene glycol Ammonia hydroxide 28% : . : 30 . 200 : 0 , , " A200 ." 400 : 3 , " , A400 ." 600 : 0 , , " A600 ." 1,200 : 3 , " , A1200 ." : " , ' 10 , . . 7090 , . : Albireo AB Arvid Wallgrens backe 20 413 46 Göteborg Sweden 2023 . : 6 200 : 171-41-37197-99 400 : 171-42-37198-99 600 : 171-43-37199-99 1,200 : 171-44-37200-99 , . , . Bylvay 200 mcg, 400 mcg, 600 mcg, 1200 mcg-PIL-1 2 23-V1 Đọc toàn bộ tài liệu